{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:02:05Z","timestamp":1769155325979,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000121","name":"NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences","doi-asserted-by":"publisher","award":["1840265"],"award-info":[{"award-number":["1840265"]}],"id":[{"id":"10.13039\/100000121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1840265"],"award-info":[{"award-number":["DMS-1840265"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Resistance to treatment, which comes from the heterogeneity of cell types within tumors, is a leading cause of poor treatment outcomes in cancer patients. Previous mathematical work modeling cancer over time has neither emphasized the relationship between cell heterogeneity and treatment resistance nor depicted heterogeneity with sufficient nuance. To respond to the need to depict a wide range of resistance levels, we develop a random differential equation model of tumor growth. Random differential equations are differential equations in which the parameters are random variables. In the inverse problem, we aim to recover the sensitivity to treatment as a probability mass function. This allows us to observe what proportions of cells exist at different sensitivity levels. After validating the method with synthetic data, we apply it to monoclonal and mixture cell population data of isogenic Ba\/F3 murine cell lines to uncover each tumor\u2019s levels of sensitivity to treatment as a probability mass function.<\/jats:p>","DOI":"10.1038\/s41540-025-00530-0","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T14:04:58Z","timestamp":1748009098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Estimating treatment sensitivity in synthetic and in vitro tumors using a random differential equation model"],"prefix":"10.1038","volume":"11","author":[{"given":"Natalie","family":"Meacham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica M.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"530_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/emmm.201101131","volume":"4","author":"NA Saunders","year":"2012","unstructured":"Saunders, N. A. et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol. Med. 4, 675\u2013684 (2012).","journal-title":"EMBO Mol. Med."},{"key":"530_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10479-011-0869-4","volume":"221","author":"J Shi","year":"2014","unstructured":"Shi, J., Alagoz, O., Erenay, F. S. & Su, Q. A survey of optimization models on cancer chemotherapy treatment planning. Ann. Oper. Res. 221, 331\u2013356 (2014).","journal-title":"Ann. Oper. Res."},{"key":"530_CR3","doi-asserted-by":"publisher","first-page":"e1005129","DOI":"10.1371\/journal.pcbi.1005129","volume":"12","author":"Q He","year":"2016","unstructured":"He, Q., Zhu, J., Dingli, D., Foo, J. & Leder, K. Z. Optimized treatment schedules for chronic myeloid leukemia. PLoS Comput. Biol. 12, e1005129 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"530_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","volume":"25","author":"JG Lohr","year":"2014","unstructured":"Lohr, J. G. et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell 25, 91\u2013101 (2014).","journal-title":"Cancer Cell"},{"key":"530_CR5","first-page":"1067","volume":"120","author":"JJ Keats","year":"2012","unstructured":"Keats, J. J. et al. Clonal competition with alternating dominance in multiple myeloma. Blood, J. Am. Soc. Hematol. 120, 1067\u20131076 (2012).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"530_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk, A., Janiszewska, M. & Polyak, K. Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer cell 37, 471\u2013484 (2020).","journal-title":"Cancer cell"},{"key":"530_CR7","doi-asserted-by":"publisher","first-page":"110162","DOI":"10.1016\/j.jtbi.2020.110162","volume":"490","author":"EB Gunnarsson","year":"2020","unstructured":"Gunnarsson, E. B., De, S., Leder, K. & Foo, J. Understanding the role of phenotypic switching in cancer drug resistance. J. Theor. Biol. 490, 110162 (2020).","journal-title":"J. Theor. Biol."},{"key":"530_CR8","doi-asserted-by":"publisher","first-page":"a033415","DOI":"10.1101\/cshperspect.a033415","volume":"8","author":"R Gatenby","year":"2018","unstructured":"Gatenby, R. & Brown, J. The evolution and ecology of resistance in cancer therapy. Cold Spring Harb. Perspect. Med. 8, a033415 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"530_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1095-8312.1972.tb00690.x","volume":"4","author":"PR Grant","year":"1972","unstructured":"Grant, P. R. Convergent and divergent character displacement. Biol. J. Linn. Soc. 4, 39\u201368 (1972).","journal-title":"Biol. J. Linn. Soc."},{"key":"530_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2307\/1933500","volume":"42","author":"JH Connell","year":"1961","unstructured":"Connell, J. H. The influence of interspecific competition and other factors on the distribution of the Barnacle Chthamalus Stellatus. Ecology 42, 710\u2013723 (1961).","journal-title":"Ecology"},{"key":"530_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jtbi.2018.07.028","volume":"455","author":"J West","year":"2018","unstructured":"West, J., Ma, Y. & Newton, P. K. Capitalizing on competition: an evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment. J. Theor. Biol. 455, 249\u2013260 (2018).","journal-title":"J. Theor. Biol."},{"key":"530_CR12","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1007\/s11538-019-00640-x","volume":"81","author":"R Brady","year":"2019","unstructured":"Brady, R. & Enderling, H. Mathematical models of cancer: when to predict novel therapies, and when not to. Bull. Math. Biol. 81, 3722\u20133731 (2019).","journal-title":"Bull. Math. Biol."},{"key":"530_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/459508a","volume":"459","author":"RA Gatenby","year":"2009","unstructured":"Gatenby, R. A. A change of strategy in the war on cancer. Nature 459, 508\u2013509 (2009).","journal-title":"Nature"},{"key":"530_CR14","doi-asserted-by":"publisher","first-page":"e84263","DOI":"10.7554\/eLife.84263","volume":"12","author":"J West","year":"2023","unstructured":"West, J. et al. A survey of open questions in adaptive therapy: bridging mathematics and clinical translation. Elife 12, e84263 (2023).","journal-title":"Elife"},{"key":"530_CR15","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","volume":"69","author":"RA Gatenby","year":"2009","unstructured":"Gatenby, R. A., Silva, A. S., Gillies, R. J. & Frieden, B. R. Adaptive therapy. Cancer Res. 69, 4894\u20134903 (2009).","journal-title":"Cancer Res."},{"key":"530_CR16","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.3390\/cancers14215319","volume":"14","author":"R Brady-Nicholls","year":"2022","unstructured":"Brady-Nicholls, R. & Enderling, H. Range-bounded adaptive therapy in metastatic prostate cancer. Cancers 14, 5319 (2022).","journal-title":"Cancers"},{"key":"530_CR17","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/app10082721","volume":"10","author":"T Phan","year":"2020","unstructured":"Phan, T. et al. Mathematical modeling of prostate cancer and clinical application. Appl. Sci. 10, 2721 (2020).","journal-title":"Appl. Sci."},{"key":"530_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01968-5","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Cunningham, J. J., Brown, J. S. & Gatenby, R. A. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat. Commun. 8, 1816 (2017).","journal-title":"Nat. Commun."},{"key":"530_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jtbi.2016.05.033","volume":"404","author":"J Yang","year":"2016","unstructured":"Yang, J., Zhao, T.-J., Yuan, C.-Q., Xie, J.-H. & Hao, F.-F. A nonlinear competitive model of the prostate tumor growth under intermittent androgen suppression. J. Theor. Biol. 404, 66\u201372 (2016).","journal-title":"J. Theor. Biol."},{"key":"530_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00332-008-9031-0","volume":"18","author":"AM Ideta","year":"2008","unstructured":"Ideta, A. M., Tanaka, G., Takeuchi, T. & Aihara, K. A mathematical model of intermittent androgen suppression for prostate cancer. J. nonlinear Sci. 18, 593\u2013614 (2008).","journal-title":"J. nonlinear Sci."},{"key":"530_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99507-2","volume":"11","author":"SC Br\u00fcningk","year":"2021","unstructured":"Br\u00fcningk, S. C. et al. Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements. Sci. Rep. 11, 20219 (2021).","journal-title":"Sci. Rep."},{"key":"530_CR22","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1158\/0008-5472.CAN-18-1804","volume":"79","author":"X Lai","year":"2019","unstructured":"Lai, X. et al. Toward personalized computer simulation of breast cancer treatment: a multiscale pharmacokinetic and pharmacodynamic model informed by multitype patient data. Cancer Res. 79, 4293\u20134304 (2019).","journal-title":"Cancer Res."},{"key":"530_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nbt.3882","volume":"35","author":"M Hafner","year":"2017","unstructured":"Hafner, M., Niepel, M. & Sorger, P. K. Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics. Nat. Biotechnol. 35, 500\u2013502 (2017).","journal-title":"Nat. Biotechnol."},{"key":"530_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41375-018-0374-8","volume":"33","author":"SM Matulis","year":"2019","unstructured":"Matulis, S. M. et al. Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma. Leukemia 33, 1291\u20131296 (2019).","journal-title":"Leukemia"},{"key":"530_CR25","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1158\/1078-0432.CCR-23-0396","volume":"29","author":"AS Bhatt","year":"2023","unstructured":"Bhatt, A. S., Schabath, M. B., Hoogland, A. I., Jim, H. S. & Brady-Nicholls, R. Patient-reported outcomes as interradiographic predictors of response in non\u2013small cell lung cancer. Clin. Cancer Res. 29, 3142\u20133150 (2023).","journal-title":"Clin. Cancer Res."},{"key":"530_CR26","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/cancers15051368","volume":"15","author":"I Harshe","year":"2023","unstructured":"Harshe, I., Enderling, H. & Brady-Nicholls, R. Predicting patient-specific tumor dynamics: how many measurements are necessary? Cancers 15, 1368 (2023).","journal-title":"Cancers"},{"key":"530_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3934\/mbe.2005.2.381","volume":"2","author":"JD Nagy","year":"2005","unstructured":"Nagy, J. D. The ecology and evolutionary biology of cancer: a review of mathematical models of necrosis and tumor cell diversity. Math. Biosci. Eng. 2, 381\u2013418 (2005).","journal-title":"Math. Biosci. Eng."},{"key":"530_CR28","doi-asserted-by":"publisher","first-page":"20210803","DOI":"10.1098\/rsif.2021.0803","volume":"19","author":"X Li","year":"2022","unstructured":"Li, X. & Thirumalai, D. A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies. J. R. Soc. Interface 19, 20210803 (2022).","journal-title":"J. R. Soc. Interface"},{"key":"530_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0022-5193(87)80171-6","volume":"128","author":"S Michelson","year":"1987","unstructured":"Michelson, S., Miller, B., Glicksman, A. & Leith, J. Tumor micro-ecology and competitive interactions. J. Theor. Biol. 128, 233\u2013246 (1987).","journal-title":"J. Theor. Biol."},{"key":"530_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00285-012-0565-2","volume":"67","author":"D Diego","year":"2013","unstructured":"Diego, D., Calvo, G. F. & P\u00e9rez-Garc\u00eda, V. M. Modeling the connection between primary and metastatic tumors. J. Math. Biol. 67, 657\u2013692 (2013).","journal-title":"J. Math. Biol."},{"key":"530_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1051\/m2an\/2012031","volume":"47","author":"A Lorz","year":"2013","unstructured":"Lorz, A., Lorenzi, T., Hochberg, M. E., Clairambault, J. & Perthame, B. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies. ESAIM Math. Model. Numer. Anal. 47, 377\u2013399 (2013).","journal-title":"ESAIM Math. Model. Numer. Anal."},{"key":"530_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11538-014-9936-8","volume":"76","author":"J Greene","year":"2014","unstructured":"Greene, J., Lavi, O., Gottesman, M. M. & Levy, D. The impact of cell density and mutations in a model of multidrug resistance in solid tumors. Bull. Math. Biol. 76, 627\u2013653 (2014).","journal-title":"Bull. Math. Biol."},{"key":"530_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11538-014-0046-4","volume":"77","author":"A Lorz","year":"2015","unstructured":"Lorz, A., Lorenzi, T., Clairambault, J., Escargueil, A. & Perthame, B. Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors. Bull. Math. Biol. 77, 1\u201322 (2015).","journal-title":"Bull. Math. Biol."},{"key":"530_CR34","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00285-018-1238-6","volume":"77","author":"E Rutter","year":"2018","unstructured":"Rutter, E., Banks, H. T. & Flores, K. Estimating intratumoral heterogeneity from spatiotemporal data. J. Math. Biol. 77, 1999\u20132022 (2018).","journal-title":"J. Math. Biol."},{"key":"530_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11538-023-01162-3","volume":"85","author":"K Nguyen","year":"2023","unstructured":"Nguyen, K., Rutter, E. M. & Flores, K. B. Estimation of parameter distributions for reaction-diffusion equations with competition using aggregate spatiotemporal data. Bull. Math. Biol. 85, 62 (2023).","journal-title":"Bull. Math. Biol."},{"key":"530_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1142\/S1793048014300023","volume":"9","author":"R Everett","year":"2014","unstructured":"Everett, R., Packer, A. & Kuang, Y. Can mathematical models predict the outcomes of prostate cancer patients undergoing intermittent androgen deprivation therapy? Biophys. Rev. Lett. 9, 173\u2013191 (2014).","journal-title":"Biophys. Rev. Lett."},{"key":"530_CR37","doi-asserted-by":"crossref","unstructured":"K\u00f6hn-Luque, A. et al. Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data. Cell Rep. Methods 3, 100417 (2023).","DOI":"10.1016\/j.crmeth.2023.100417"},{"key":"530_CR38","first-page":"1544","volume":"25","author":"HE Skipper","year":"1965","unstructured":"Skipper, H. E. The effects of chemotherapy on the kinetics of leukemic cell behavior. Cancer Res. 25, 1544\u20131550 (1965).","journal-title":"Cancer Res."},{"key":"530_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11095-025-03858-8","volume":"42","author":"L Podina","year":"2025","unstructured":"Podina, L., Ghodsi, A. & Kohandel, M. Learning Chemotherapy Drug Action via Universal Physics-Informed Neural Networks. Pharm. Res. 42, 593\u2013612 (2025).","journal-title":"Pharm. Res."},{"key":"530_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.aml.2017.05.005","volume":"74","author":"HT Banks","year":"2017","unstructured":"Banks, H. T. & Joyner, M. L. Aic under the framework of least squares estimation. Appl. Math. Lett. 74, 33\u201345 (2017).","journal-title":"Appl. Math. Lett."},{"key":"530_CR41","first-page":"415","volume":"22","author":"H Banks","year":"2018","unstructured":"Banks, H. et al. The prohorov metric framework and aggregate data inverse problems for random PDEs. Commun. Appl. Anal. 22, 415 (2018).","journal-title":"Commun. Appl. Anal."},{"key":"530_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3934\/dcdsb.2017050","volume":"22","author":"EM Rutter","year":"2017","unstructured":"Rutter, E. M. & Kuang, Y. Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer. DCDS-B 22, 1001\u20131021 (2017).","journal-title":"DCDS-B"},{"key":"530_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15424-4","volume":"11","author":"R Brady-Nicholls","year":"2020","unstructured":"Brady-Nicholls, R. et al. Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation. Nat. Commun. 11, 1750 (2020).","journal-title":"Nat. Commun."},{"key":"530_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtbi.2018.09.022","volume":"459","author":"JJ Cunningham","year":"2018","unstructured":"Cunningham, J. J., Brown, J. S., Gatenby, R. A. & Sta\u0148kov\u00e1, K. Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer. J. Theor. Biol. 459, 67\u201378 (2018).","journal-title":"J. Theor. Biol."},{"key":"530_CR45","doi-asserted-by":"crossref","unstructured":"Banks, H. T. A functional analysis framework for modeling, estimation and control in science and engineering (CRC Press, 2012).","DOI":"10.1201\/b12209"},{"key":"530_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1515\/jip-2012-0037","volume":"20","author":"HT Banks","year":"2012","unstructured":"Banks, H. T., Kenz, Z. R. & Thompson, W. C. A review of selected techniques in inverse problem nonparametric probability distribution estimation. J. Inverse Ill. Posed Probl. 20, 429\u2013460 (2012).","journal-title":"J. Inverse Ill. Posed Probl."},{"key":"530_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/17415977.2017.1316498","volume":"26","author":"H Banks","year":"2018","unstructured":"Banks, H., Flores, K. B., Langlois, C. R., Serio, T. R. & Sindi, S. S. Estimating the rate of prion aggregate amplification in yeast with a generation and structured population model. Inverse Probl. Sci. Eng. 26, 257\u2013279 (2018).","journal-title":"Inverse Probl. Sci. Eng."},{"key":"530_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.automatica.2019.04.026","volume":"106","author":"M Sirlanci","year":"2019","unstructured":"Sirlanci, M. et al. Estimating the distribution of random parameters in a diffusion equation forward model for a transdermal alcohol biosensor. Automatica 106, 101\u2013109 (2019).","journal-title":"Automatica"},{"key":"530_CR49","doi-asserted-by":"publisher","first-page":"7299","DOI":"10.3934\/mbe.2019365","volume":"16","author":"C Schacht","year":"2019","unstructured":"Schacht, C., Meade, A., Banks, H., Enderling, H. & Abate-Daga, D. Estimation of probability distributions of parameters using aggregate population data: analysis of a car t-cell cancer model. Math. Biosci. Eng. 16, 7299\u20137326 (2019).","journal-title":"Math. Biosci. Eng."},{"key":"530_CR50","doi-asserted-by":"publisher","first-page":"105999","DOI":"10.1016\/j.aml.2019.105999","volume":"100","author":"H Banks","year":"2020","unstructured":"Banks, H. et al. Parameter estimation using aggregate data. Appl. Math. Lett. 100, 105999 (2020).","journal-title":"Appl. Math. Lett."},{"key":"530_CR51","doi-asserted-by":"crossref","unstructured":"Everett, R. et al. A tutorial review of mathematical techniques for quantifying tumor heterogeneity. Math. Biosci. Eng. 17, 3660-3709 (2020).","DOI":"10.3934\/mbe.2020207"},{"key":"530_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1017\/S0370164600014346","volume":"55","author":"AC Aitken","year":"1936","unstructured":"Aitken, A. C. Iv.-on least squares and linear combination of observations. Proc. R. Soc. Edinb. 55, 42\u201348 (1936).","journal-title":"Proc. R. Soc. Edinb."},{"key":"530_CR53","doi-asserted-by":"publisher","unstructured":"Akaike, H. Information Theory and an Extension of the Maximum Likelihood Principle, 199\u2013213 (Springer New York, New York, NY, 1998). https:\/\/doi.org\/10.1007\/978-1-4612-1694-0_15.","DOI":"10.1007\/978-1-4612-1694-0_15"},{"key":"530_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF02294361","volume":"52","author":"H Bozdogan","year":"1987","unstructured":"Bozdogan, H. Model selection and Akaike\u2019s information criterion (AIC): the general theory and its analytical extensions. Psychometrika 52, 345\u2013370 (1987).","journal-title":"Psychometrika"}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00530-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T15:04:50Z","timestamp":1748012690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00530-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00530-0","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}